Finance
Results: 3625-3636 of 47908

Newronika Receives CE Mark for αDBS®, Advancing Its Mission to Make Adaptive Therapy the Standard of Care

Thailand Advances Net Zero 2050 through Public–Private 'ONE MIND' Collaboration TCMA Launches 'The NEXT Chapter' to Position Industry as a Climate Solution Partner

HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction








